Response to antiseizure medications in neonates with acute symptomatic seizures

the Neonatal Seizure Registry Study Group

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


In a prospective cohort of 534 neonates with acute symptomatic seizures, 66% had incomplete response to the initial loading dose of antiseizure medication (ASM). Treatment response did not differ by gestational age, sex, medication, or dose. The risk of incomplete response was highest for seizures due to intracranial hemorrhage and lowest for hypoxic-ischemic encephalopathy, although the difference was not significant after adjusting for high seizure burden and therapeutic hypothermia treatment. Future trial design may test ASMs in neonates with all acute symptomatic seizure etiologies and could target neonates with seizures refractory to an initial ASM.

Original languageEnglish
Pages (from-to)e20-e24
Issue number3
StatePublished - Mar 2019


  • AED
  • antiepileptic drug
  • electroencephalogram
  • epilepsy
  • hypoxic-ischemic encephalopathy
  • neonatal encephalopathy
  • neonatal seizures
  • neurocritical care
  • seizure


Dive into the research topics of 'Response to antiseizure medications in neonates with acute symptomatic seizures'. Together they form a unique fingerprint.

Cite this